KRAS and neoplasm: In this study, we first subjected PDAC gene expression profiles and mutation data retrieved from public databases [i.e., The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC)] to tumor mutation profile and copy number variation (CNV) analyses to establish a prediction model of KRAS mutations based on survival analysis and mRNA expression.